From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

"The Pain Was Relieved by Nitro": Helpful Information?

Results from this study defy conventional wisdom about patients who present with chest pain to emergency departments.

Relief with nitroglycerin is thought by some to be characteristic of anginal chest pain. What is the prognostic value of this clinical observation? Researchers in Maryland prospectively studied 459 patients who received nitroglycerin (0.4 mg) after they presented with chest pain to an emergency department.

Symptom relief was defined as ≥50% decrease in self-reported chest pain within 5 minutes of receiving nitroglycerin. Active CAD was defined as ≥70% stenosis on cardiac catheterization; any serum troponin T elevation; a positive exercise-test result; or physician diagnosis of CAD, confirmed by a cardiologist who was blinded to nitroglycerin-relief status.

Active CAD was present in 141 patients (31%). Nitroglycerin relieved chest pain in 181 patients (39%): 35% of those with active CAD (sensitivity) and 41% of those without active CAD (specificity, 59%). Likelihood ratios indicated that neither relief nor lack of relief with nitroglycerin predicted active CAD.

Comment: The authors point out that some practice guidelines include nitroglycerin relief as a feature to consider when determining chest-pain etiology, but that prognostic decision rules generated by some research studies have not included nitroglycerin relief. In this study, nitroglycerin response had no prognostic or diagnostic value in patients who presented with chest pain to the ED. However, an editorialist notes that the pathophysiology of chronic stable angina differs from that of acute coronary syndromes and that for outpatients with ongoing chest pain that could be anginal, nitroglycerin response does help to estimate the probability of CAD.

— Richard Saitz, MD, MPH, FACP, FASAM

Published in Journal Watch General Medicine January 16, 2004

Citation(s):

Henrikson CA et al. Chest pain relief by nitroglycerin does not predict active coronary artery disease. Ann Intern Med 2003 Dec 16; 139:979-86.

Gibbons RJ. Nitroglycerin: Should we still ask? Ann Intern Med 2003 Dec 16; 139:1036-7.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2004. Massachusetts Medical Society. All rights reserved.